| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| TG2-M82H5 | Mouse | Biotinylated Mouse TGF-beta RII / TGFBR2 Protein, His,Avitag™ |  |
|
|
| TG2-H52H5 | Human | Human TGF-beta RII / TGFBR2 Protein, His Tag |  |
|
|
| TG2-H82E4 | Human | Biotinylated Human TGF-beta RII / TGFBR2 Protein, His,Avitag™ |  |
|
|
| TG2-H82F6 | Human | Biotinylated Human TGF-beta RII / TGFBR2 Protein, Fc,Avitag™ (MALS verified) |  |
|
|
| TG2-H5252 | Human | Human TGF-beta RII / TGFBR2 Protein, Fc Tag (MALS verified) |  |
|
|
Serial dilutions of Human TGF-beta RII, His Tag (Cat. No. TG2-H52H5) were added into Human Latent TGFB1, His Tag (Cat. No. TG1-H524x) : Biotinylated Human TGF-beta RII, His,Avitag (Cat. No. TG2-H82E4) binding reactions. The half maximal inhibitory concentration (IC50) is 0.39287 μg/mL (QC tested).
The purity of Biotinylated Human TGFBR2, Fc,Avitag (Cat. No. TG2-H82F6) is more than 90% and the molecular weight of this protein is around 110-125 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| TASO-001 | TASO-001; ATB-301 | Details | |||
| IMC-TR1 | IMC-TR1; LY-3022859 | Eli Lilly And Company | Details | ||
| Adoptive Cell Therapy (Oslo University Hospital) | Oslo University Hospital | Details | |||
| YH-14618 | P2K; YH14618; Peniel 2K; Peniel-2000 | Yuhan Corp | Details | ||
| HCW-9218 | HCW-9218 | Phase 2 Clinical | HCW Biologics Inc | Solid tumours; Pancreatic Neoplasms; Pulmonary Fibrosis | Details |
This web search service is supported by Google Inc.
A-Z
FLAG
Star Staining
ViruStop
Aneuro
ComboX
ActiveMax
GENPower
ClinMax 
